PAR HEALTH: ELEVATING THE ESSENTIALS
Live / Registered — Registered (as of 09 Jun 2026)
What this means for you
Registered since 09 Jun 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79437203
- Registration number
- 8290339
- Mark type
- Stylized text
- Filed
- 07 Oct 2025
- Published for opposition
- 21 Apr 2026
- Registered
- 09 Jun 2026
- Attorney of record
- Camille M. Miller
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the treatment of pain management, infectious diseases, central nervous system disorders, namely epilepsy, anxiety, and depression, hypertension, cholesterol management, heart disease, acid reflex, ulcers and irritable bowel syndrome, diabetes, thyroid disorders, side effects of cancer treatments, bone diseases, allergic reactions, shock, malignant diseases, and kidney disorders; pharmaceutical preparations for the treatment of pain management, infectious diseases, central nervous system disorders, namely epilepsy, anxiety, and depression, hypertension, cholesterol management, heart disease, acid reflex, ulcers and irritable bowel syndrome, diabetes, thyroid disorders, side effects of cancer treatments, bone diseases, allergic reactions, shock, malignant diseases, and kidney disorders; ready-to-administer injectable pharmaceutical preparations for the treatment of allergic reactions, hypotension, shock, malignant diseases, and kidney disorders, and to provide and reverse muscle relaxation to be used in patient care facilities, namely, hospitals, acute care facilities, and long term care facilities; radio frequency identification tagged pharmaceutical products, namely, sympathomimetic agents, diagnostic agents, anticoagulants, thrombin inhibitors, anesthetics, analgesics, endocrine metabolics, antibacterial agents, antibiotics, skeletal muscle relaxants, injectable estrogens, diuretic agents, psychiatrics, antivirals, thyroid agents, corticosteroids, antifungals, immunosuppressive agents, parasympathomimetic agents, vasoconstrictors, oxytocic agents, antiemetics, vasopressin antagonists, vasodilators, vasopressors, anti-epileptics, anticonvulsants, cholinesterase inhibitors, and antimuscarinic agents.
- Class 035 — Advertising and business services: Outsourcing services in the nature of arranging procurement of goods for others in the field of pharmaceuticals; business administration of patient reimbursement programs for pharmaceuticals; business administration of patient assistance programs that provide pharmaceuticals to help patients with insufficient resources get treatment at little or no cost to the patient.
- Class 040 — Treatment of materials: Custom manufacture of pharmaceutical products to the order and specification of others; providing technical information in the field of pharmaceutical manufacturing.
- Class 042 — Scientific and technological services: Development of pharmaceutical preparations and medicines; pharmaceutical drug development services; pharmaceutical research and development; pharmaceutical research services.
- Class 044 — Medical, beauty and agricultural services: Charitable services, namely patient assistance programs that provide pharmaceuticals to help patients with low income get pharmaceuticals at little or no cost to the patient.
Owner
- PH Health Limited, IE
- PH Health Limited, IE
- PH Health Limited, IE
Prosecution history
- 09 Sept 2026 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 09 Jun 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 09 Jun 2026 — REGISTERED-PRINCIPAL REGISTER
- 21 Apr 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 Apr 2026 — PUBLISHED FOR OPPOSITION
- 15 Apr 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 09 Apr 2026 — REFUSAL PROCESSED BY IB
- 26 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 25 Mar 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 25 Mar 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 25 Mar 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 21 Mar 2026 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 21 Mar 2026 — REFUSAL PROCESSED BY MPU
- 05 Mar 2026 — NEW REPRESENTATIVE AT IB RECEIVED
- 18 Feb 2026 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW